Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1985-1-24
|
pubmed:abstractText |
The records of 90 patients with Wolff-Parkinson-White syndrome who presented with supraventricular tachycardia in the first 4 months of life were reviewed. Among these, 63% were male. Structural heart disease was present in 20%, most commonly Ebstein's anomaly. All patients presented with a regular narrow QRS tachycardia, and pre-excitation became evident only when normal sinus rhythm was established. Only one infant had atrial flutter and none had atrial fibrillation. Type A Wolff-Parkinson-White syndrome was most common (49%), with heart disease occurring in only 5% of these patients. In contrast, heart disease was identified in 45% of those with type B syndrome. Initially, normal sinus rhythm was achieved in 88% of the 66 infants treated with digoxin with no deaths. Normal sinus rhythm resumed after electrical countershock in 87% of the 15 infants so treated. Maintenance digoxin therapy was used in 85 patients. The Wolff-Parkinson-White pattern disappeared in 36% of the patients. Four infants died of cardiac causes during the mean follow-up period of 6.5 years. Two of these four infants had congenital heart disease; the third, with a normal heart initially, developed ventricular fibrillation and died from a cardiomyopathy considered related to resuscitation. The remaining infant, with a normal heart, died suddenly at 1 month of age. All were receiving digoxin. A wide QRS tachycardia later appeared in three patients, all with heart disease, one of whom died.(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0735-1097
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
130-5
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3964800-Combined Modality Therapy,
pubmed-meshheading:3964800-Digoxin,
pubmed-meshheading:3964800-Ebstein Anomaly,
pubmed-meshheading:3964800-Electric Countershock,
pubmed-meshheading:3964800-Electrophysiology,
pubmed-meshheading:3964800-Female,
pubmed-meshheading:3964800-Follow-Up Studies,
pubmed-meshheading:3964800-Heart Conduction System,
pubmed-meshheading:3964800-Humans,
pubmed-meshheading:3964800-Infant,
pubmed-meshheading:3964800-Infant, Newborn,
pubmed-meshheading:3964800-Male,
pubmed-meshheading:3964800-Recurrence,
pubmed-meshheading:3964800-Sinoatrial Node,
pubmed-meshheading:3964800-Tachycardia,
pubmed-meshheading:3964800-Wolff-Parkinson-White Syndrome
|
pubmed:year |
1985
|
pubmed:articleTitle |
Wolff-Parkinson-White syndrome and supraventricular tachycardia during infancy: management and follow-up.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|